68475-003-04 : NDC 2026 Code

68475-003-04 : Ribavirin ( Ribavirin )

Additionally :

You can get information about “68475-003-04” NDC code in 68475-003-04 in HTML format

HTML | 68475-003-04 in TXT (Plain Text) format

TXT | 68475-003-04 in PDF (Portable Document Format)

PDF | 68475-003-04 in XML format

XML formats.

NDC Code : 68475-003-04 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68475-003-04",
    "PackageDescription": "4 VIAL in 1 CARTON (68475-003-04)  &gt; 1 POWDER, FOR SOLUTION in 1 VIAL",
    "NDC11Code": "68475-0003-04",
    "ProductNDC": "68475-003",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ribavirin",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ribavirin",
    "DosageFormName": "POWDER, FOR SOLUTION",
    "RouteName": "RESPIRATORY (INHALATION)",
    "StartMarketingDate": "20200421",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA207366",
    "LabelerName": "Navinta LLC",
    "SubstanceName": "RIBAVIRIN",
    "StrengthNumber": "6",
    "StrengthUnit": "g/1",
    "Pharm_Classes": "Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2022-12-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20200421",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}